Harth, Günter <br/><br/>
Targeting the Mycobacterium tuberculosis 30/32-kDa mycolyl transferase complex as a therapeutic strategy against tuberculosis: Proof of principle by using antisense technology.  [electronic resource] 

 -  Proceedings of the National Academy of Sciences of the United States of America  Nov 2002 
 - 15614-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0027-8424 
<br/><br/><label>Standard No.: </label>10.1073/pnas.242612299  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acyltransferases--biosynthesis<br/>Alanine Racemase--drug effects<br/>Antigens, Bacterial--biosynthesis<br/>Bacterial Proteins--biosynthesis<br/>Carrier Proteins--biosynthesis<br/>Cell Division--drug effects<br/>Drug Design<br/>Drug Evaluation, Preclinical<br/>Gene Expression Regulation, Bacterial--drug effects<br/>Glutamate-Ammonia Ligase--drug effects<br/>Multienzyme Complexes--drug effects<br/>Mycobacterium tuberculosis--drug effects<br/>Oligodeoxyribonucleotides, Antisense--chemistry<br/>RNA, Bacterial--antagonists & inhibitors<br/>RNA, Messenger--antagonists & inhibitors<br/>Thionucleotides--chemistry<br/>Time Factors<br/>Transcription, Genetic--drug effects<br/>Tuberculosis--drug therapy